Loading company…
Neuroplast develops autologous stem cell therapies for neurodegenerative conditions using its Neuro-Cells platform.
Founded in 2014 and based in Geleen, Netherlands, Neuroplast B.V. develops treatments for neurodegenerative conditions. Its Neuro-Cells platform uses the patient's own cells to promote healing and regeneration, targeting traumatic brain and spinal cord injuries as well as Alzheimer's and Parkinson's diseases. Revenue comes from supplying the therapy to hospitals and specialized clinics. The company has raised EUR 4.000 mn from Brightlands Venture Partners, Industriebank LIOF and Lumana Invest, and CEO Johannes de Munter leads it.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in